Global Health (MEDANTA)₹1,427+2.12%Hospital
In the Jun 2026 quarter (consolidated), Global Health reported sales of ₹1,303 Cr, up 26.4% from Jun 2025, and net profit of ₹157 Cr, down 1.3% year on year. For the year to Mar 2026, sales were ₹4,409 Cr and net profit ₹553 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 843 | 836 | 809 | 861 | 957 | 944 | 931 | 1,031 | 1,099 | 1,122 | 1,159 | 1,303 |
| Expenses | 628 | 617 | 626 | 672 | 726 | 703 | 704 | 781 | 864 | 900 | 911 | 1,013 |
| Operating Profit | 213 | 216 | 179 | 186 | 228 | 238 | 225 | 247 | 231 | 217 | 244 | 287 |
| OPM % | 25.0% | 26.0% | 21.9% | 21.9% | 24.0% | 25.0% | 24.0% | 24.0% | 21.0% | 19.0% | 21.0% | 22.0% |
| Other Income | 21.04 | 18.04 | 27.08 | 22.05 | 18.03 | 16.02 | −27.08 | 20.04 | 36.08 | −15.03 | 37.05 | 22.06 |
| Interest | 19.99 | 17.98 | 17.97 | 17.99 | 15.99 | 15.98 | 14.99 | 13.99 | 16.98 | 21.99 | 26.96 | 26.97 |
| Depreciation | 43.10 | 44.09 | 45.08 | 47.10 | 49.12 | 48.08 | 49.13 | 45.06 | 50.07 | 61.15 | 67.11 | 69.17 |
| Profit before tax | 171 | 172 | 143 | 144 | 181 | 189 | 133 | 208 | 200 | 120 | 187 | 213 |
| Tax % | 27.0% | 27.9% | 11.0% | 25.9% | 27.9% | 24.0% | 24.0% | 23.9% | 20.9% | 20.9% | 24.0% | 26.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −36.06 | 0.00 | 13.04 | −29.07 | 0.00 | 0.00 |
| Net Profit | 125 | 124 | 127 | 106 | 131 | 143 | 101 | 159 | 158 | 94.92 | 142 | 157 |
| EPS (Rs) | 4.67 | 4.60 | 4.75 | 3.97 | 4.88 | 5.33 | 3.79 | 5.91 | 5.90 | 3.55 | 5.35 | 5.91 |
| Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,383 | 1,343 | 1,455 | 1,500 | 1,447 | 2,166 | 2,711 | 3,275 | 3,690 | 4,409 | 4,683 |
| Expenses | 1,076 | 1,214 | 1,279 | 1,304 | 1,245 | 1,701 | 2,065 | 2,456 | 2,794 | 3,476 | 3,688 |
| Operating Profit | 301 | 125 | 172 | 192 | 197 | 457 | 636 | 808 | 885 | 918 | 978 |
| OPM % | 22.0% | 9.0% | 12.0% | 12.9% | 14.0% | 21.0% | 24.0% | 24.9% | 24.0% | 21.0% | 20.9% |
| Other Income | 45.07 | 49.13 | 50.09 | 44.10 | 31.04 | 39.08 | 49.13 | 75.21 | 29.08 | 98.15 | 80.16 |
| Interest | 13.99 | 27.99 | 37.98 | 56.92 | 72.94 | 85.97 | 85.97 | 83.88 | 73.99 | 78.90 | 92.90 |
| Depreciation | 70.15 | 86.11 | 102 | 115 | 123 | 130 | 150 | 173 | 195 | 223 | 248 |
| Profit before tax | 262 | 60.01 | 83.01 | 64.01 | 31.99 | 281 | 449 | 627 | 647 | 715 | 720 |
| Tax % | 34.9% | 45.0% | 37.9% | 43.0% | 11.0% | 29.9% | 26.9% | 24.0% | 26.0% | 23.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | −37.06 | −1.01 | −16.03 |
| Net Profit | 170 | 32.94 | 50.96 | 35.95 | 28.96 | 196 | 326 | 477 | 481 | 553 | 551 |
| EPS (Rs) | 35.09 | 6.79 | 10.45 | 7.37 | 5.80 | 7.76 | 12.17 | 17.82 | 17.93 | 20.69 | 20.71 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 48.16 | 48.17 | 49.19 | 49.18 | 50.16 | 51.21 | 54.15 | 54.20 | 54.22 | 54.23 |
| Reserves | 978 | 1,137 | 1,247 | 1,302 | 1,334 | 1,567 | 2,380 | 2,857 | 3,337 | 3,914 |
| Borrowings | 165 | 456 | 788 | 930 | 931 | 1,109 | 1,122 | 802 | 718 | 1,191 |
| Other Liabilities | 294 | 344 | 349 | 386 | 381 | 420 | 544 | 571 | 663 | 750 |
| Total Liabilities | 1,486 | 1,986 | 2,434 | 2,667 | 2,696 | 3,148 | 4,099 | 4,284 | 4,772 | 5,909 |
| Fixed Assets | 914 | 1,096 | 1,196 | 1,704 | 1,618 | 1,777 | 2,052 | 2,240 | 2,519 | 3,799 |
| CWIP | 12.04 | 318 | 669 | 383 | 465 | 440 | 328 | 389 | 535 | 132 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.01 | 3.01 |
| Other Assets | 559 | 572 | 570 | 581 | 614 | 929 | 1,719 | 1,655 | 1,715 | 1,975 |
| Inventories | 28.09 | 23.05 | 23.05 | 39.13 | 40.11 | 53.17 | 60.17 | 67.19 | 67.20 | 79.23 |
| Trade receivables | 74.82 | 152 | 164 | 149 | 134 | 180 | 193 | 214 | 291 | 410 |
| Cash & equivalents | 375 | 259 | 265 | 249 | 288 | 511 | 1,275 | 1,172 | 1,120 | 1,127 |
| Total Assets | 1,486 | 1,986 | 2,434 | 2,667 | 2,696 | 3,148 | 4,099 | 4,284 | 4,772 | 5,909 |
| Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 227 | 62.86 | 166 | 175 | 241 | 310 | 644 | 611 | 623 | 713 |
| Cash from investing activity | −241 | −68.95 | −249 | −86.94 | −239 | −420 | −341 | −441 | −720 | −1,088 |
| Cash from financing activity | −6.98 | 8.96 | 96.56 | −0.99 | −80.64 | 159 | 345 | −512 | −96.67 | 271 |
| Net cash flow | −20.03 | 3.01 | 14.03 | 87.12 | −78.10 | 50.08 | 649 | −344 | −194 | −103 |
| Capex | 156 | 144 | 299 | 187 | 146 | 273 | 235 | 278 | 515 | 976 |
| Free cash flow | 71.10 | −81.06 | −133 | −13.01 | 100 | 38.04 | 409 | 335 | 110 | −263 |
| CFO / OP % | 107.9% | 93.0% | 135.0% | 121.0% | 131.0% | 89.0% | 118.0% | 98.0% | 89.0% | 91.0% |
| Mar 2016 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 19 | 40 | 40 | 35 | 33 | 29 | 25 | 23 | 28 | 33 |
| Inventory days | 27 | 25 | 25 | 42 | 41 | 35 | 34 | 31 | 27 | 28 |
| Days payable | 91 | 123 | 141 | 146 | 137 | 89 | 113 | 89 | 80 | 88 |
| Cash conversion cycle | −44 | −55 | −74 | −66 | −61 | −23 | −51 | −33 | −23 | −25 |
| Working capital days | −24 | −34 | −19 | −32 | −49 | −21 | −38 | −33 | −22 | −8 |
| ROCE % | — | — | 6.0% | 6.0% | 5.0% | 15.0% | 17.0% | 20.0% | 20.0% | 17.0% |
For the Jun 2026 quarter, Global Health reported sales of ₹1,303 Cr, up 26.4% year on year and net profit of ₹157 Cr, down 1.3% year on year. The operating margin was 22.0%.
Global Health's sales for the year to Mar 2026 were ₹4,409 Cr; over the last twelve months they were ₹4,683 Cr.
Net profit for the year to Mar 2026 was ₹553 Cr, and ₹551 Cr over the last twelve months. Earnings per share over the same trailing period were ₹20.71.
Global Health reported borrowings of ₹1,191 Cr at Mar 2026, against cash and equivalents of ₹1,127 Cr.
Cash from operations was ₹713 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹263 Cr.